Financial Gravity Asset Management, Inc. Eli Lilly & CO Transaction History

Financial Gravity Asset Management, Inc.

$400 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $37,900 - $50,705	64 Added 1600.0%	68 $51.9 Million
Q4 2023 Jun 26, 2024	SELL	$525.19 - $619.13 $10,503 - $12,382	-20 Reduced 29.41%	48 $28.2 Million
Q3 2023 Nov 15, 2023	SELL	$434.7 - $599.3 $202,135 - $278,674	-465 Reduced 99.15%	4 $2,000
Q2 2023 Aug 08, 2023	BUY	$350.74 - $468.98 $44,193 - $59,091	126 Added 36.73%	469 $9.01 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $7,144 - $8,390	-23 Reduced 6.28%	343 $44,000
Q4 2022 Feb 15, 2023	SELL	$321.55 - $374.67 $401,615 - $467,962	-1,249 Reduced 77.34%	366 $8.21 Million
Q3 2022 Nov 03, 2022	SELL	$296.48 - $337.87 $1.73 Million - $1.97 Million	-5,837 Reduced 78.33%	1,615 $21,000
Q2 2022 Aug 05, 2022	BUY	$278.73 - $327.27 $1.68 Million - $1.97 Million	6,022 Added 421.12%	7,452 $2.49 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $1.28 Million - $1.6 Million	-5,470 Reduced 79.28%	1,430 $22,000
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $1.55 Million - $1.93 Million	6,900 New	6,900 $3.44 Million
Q2 2021 Aug 11, 2021	SELL	$180.55 - $233.54 $2,708 - $3,503	-15 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $2,136 - $2,765	13 Added 650.0%	15 $2.84 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $260 - $345	2 New	2 $0
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $15,688 - $18,880	-115 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$119.05 - $147.35 $5,238 - $6,483	44 Added 61.97%	115 $15,000
Q4 2019 Feb 28, 2020	SELL	$106.92 - $132.43 $3,849 - $4,767	-36 Reduced 33.64%	71 $131,000
Q3 2019 Oct 15, 2019	BUY	$106.79 - $116.16 $5,553 - $6,040	52 Added 94.55%	107 $12,000
Q2 2019 Jul 26, 2019	SELL	$110.79 - $129.32 $43,540 - $50,822	-393 Reduced 87.72%	55 $6,000
Q1 2019 Apr 19, 2019	BUY	$111.31 - $131.02 $43,299 - $50,966	389 Added 659.32%	448 $58,000
Q3 2018 Oct 31, 2018	BUY	$85.86 - $107.31 $171 - $214	2 Added 3.51%	59 $6,000
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $9,235 - $10,599	-122 Reduced 68.16%	57 $6,000
Q1 2018 May 23, 2018	BUY	$74.21 - $87.6 $13,283 - $15,680	179 New	179 $14,000

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$76.4 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$58.1 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$51.9 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$40.5 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$26.7 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.

Account